Human Tissue Microarray (LC0100-02A)
NSCLC Tumor Tissue Microarray - 1 core per case
- 40 Adenocarcinoma cases
- 46 Squamous cell carcinoma cases
- 1 Spindle cell carcinoma case
- 1 Micropapillary adenocarcinoma case
- 1 Adenosquamous carcinoma case
- 1 neuroendocrine carcioma case
- 3 Small Cell Lung cancer cases
- 7 Normal/NAT cases
- Overlap cases with LC0100-02B
$295.00
| Species | Human |
|---|---|
| Section Thickness | 5 µm |
| Fixative | Formalin |
| Total Cases | 100 |
| Total Cores | 100 |
| Core Diameter | 1.0 mm |
| Storage | Short term RT |
| Usage | For research use only. Designed for Immunohistochemistry (IHC) and In Situ Hybridization (ISH) |
USBIOLAB
- A
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- B
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- C
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- D
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- E
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- F
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- G
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- H
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- I
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- J
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
- LU
-
No.
-
Map ID
-
Age
-
Sex
-
Organ
-
Pathology Diagnosis
-
Grade
-
TNM
-
Stage
-
Type
-
Block ID
| No. | Map ID | Age | Sex | Organ | Pathology Diagnosis | Grade | TNM | Stage | Type | Block ID |
|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
A1
|
54
|
M
|
Lung
|
Adenocarcinoma
|
G2
|
T1bN1M0
|
IIB
|
Malignant Primary
|
2106067
|
|
2
|
A2
|
54
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
T1cN0M0
|
IA3
|
Malignant Primary
|
463966
|
|
3
|
A3
|
64
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21117111A
|
|
4
|
A4
|
64
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
T1bN0M0
|
IA2
|
Malignant Primary
|
2110786
|
|
5
|
A5
|
61
|
M
|
Lung
|
Adenocarcinoma
|
G2
|
T1bN2M0
|
IIIA
|
Malignant Primary
|
2014178
|
|
6
|
A6
|
38
|
M
|
Lung
|
Adenocarcinoma (Sparse)
|
G2
|
T1cN2M0
|
IIIA
|
Malignant Primary
|
2110016
|
|
7
|
A7
|
38
|
F
|
Lung
|
Adenocarcinoma
|
G1
|
T1aN0M0
|
IA1
|
Malignant Primary
|
464934
|
|
8
|
A8
|
57
|
F
|
Lung
|
Spindle Cell carcinoma
|
-
|
-
|
-
|
Malignant Primary
|
2106156
|
|
9
|
A9
|
45
|
F
|
Lung
|
Squamous Cell Carcinoma
|
G1
|
-
|
IIIA
|
Malignant Primary
|
2013364
|
|
10
|
A10
|
58
|
F
|
Lung
|
Squamous Cell Carcinoma
|
G1
|
-
|
-
|
Malignant Primary
|
NSCLC-158
|
|
11
|
B1
|
73
|
F
|
Lung
|
Adenocarcinoma
|
G3
|
-
|
-
|
Malignant Primary
|
NSCLC-111
|
|
12
|
B2
|
67
|
M
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
18-27879
|
|
13
|
B3
|
64
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
19-10305A
|
|
14
|
B4
|
73
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
19-2127A
|
|
15
|
B5
|
76
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
20-31189D
|
|
16
|
B6
|
62
|
F
|
Lung
|
Normal Tissue
|
-
|
-
|
-
|
NAT
|
17-35842C
|
|
17
|
B7
|
65
|
M
|
Lung
|
Adenocarcinoma
|
G3
|
-
|
-
|
Malignant Primary
|
14-6285E
|
|
18
|
B8
|
62
|
M
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21111072A
|
|
19
|
B9
|
66
|
M
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21111078A
|
|
20
|
B10
|
61
|
M
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21111084A
|
|
21
|
C1
|
73
|
M
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21111367A
|
|
22
|
C2
|
72
|
F
|
Lung
|
Adenocarcinoma
|
G1
|
-
|
-
|
Malignant Primary
|
21111374A
|
|
23
|
C3
|
74
|
M
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21111380A
|
|
24
|
C4
|
63
|
M
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21111381A
|
|
25
|
C5
|
71
|
F
|
Lung
|
Adenocarcinoma
|
G1
|
-
|
-
|
Malignant Primary
|
21111581A
|
|
26
|
C6
|
55
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
T1N0M0
|
IA
|
Malignant Primary
|
21110484A
|
|
27
|
C7
|
60
|
F
|
Lung
|
Adenocarcinoma with epithelial interstitial transformation (EMT)
|
G3
|
-
|
-
|
Malignant Primary
|
21117090A
|
|
28
|
C8
|
70
|
M
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21117091A
|
|
29
|
C9
|
75
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21117092A
|
|
30
|
C10
|
65
|
M
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21117094A
|
|
31
|
D1
|
53
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21117095A
|
|
32
|
D2
|
70
|
M
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21117096A
|
|
33
|
D3
|
50
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21117097A
|
|
34
|
D4
|
65
|
F
|
Lung
|
Adenocarcinoma
|
G3
|
-
|
-
|
Malignant Primary
|
21117098A
|
|
35
|
D5
|
74
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21117099A
|
|
36
|
D6
|
55
|
M
|
Lung
|
Adenocarcinoma
|
G1
|
-
|
-
|
Malignant Primary
|
21117101A
|
|
37
|
D7
|
47
|
M
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21117102A
|
|
38
|
D8
|
68
|
M
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21117103A
|
|
39
|
D9
|
52
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21117104A
|
|
40
|
D10
|
51
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21117105A
|
|
41
|
E1
|
60
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21117106A
|
|
42
|
E2
|
66
|
F
|
Lung
|
Adenocarcinoma
|
G1
|
-
|
-
|
Malignant Primary
|
21117108A
|
|
43
|
E3
|
71
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21117109A
|
|
44
|
E4
|
31
|
F
|
Lung
|
Normal TIssue
|
-
|
-
|
-
|
NAT
|
21117110A
|
|
45
|
E5
|
44
|
F
|
Lung
|
Adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21117112A
|
|
46
|
E6
|
54
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110025TMA
|
|
47
|
E7
|
71
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110032TMA
|
|
48
|
E8
|
76
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G1
|
-
|
-
|
Malignant Primary
|
21110035TMA
|
|
49
|
E9
|
67
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110043TMA
|
|
50
|
E10
|
69
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110050TMA
|
|
51
|
F1
|
68
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110051TMA
|
|
52
|
F2
|
53
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110052TMA
|
|
53
|
F3
|
65
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110055TMA
|
|
54
|
F4
|
61
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G3
|
-
|
-
|
Malignant Primary
|
21110059TMA
|
|
55
|
F5
|
54
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110061TMA
|
|
56
|
F6
|
59
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110062TMA
|
|
57
|
F7
|
69
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G3
|
-
|
-
|
Malignant Primary
|
21110064TMA
|
|
58
|
F8
|
52
|
M
|
Lung
|
Micropapillary adenocarcinoma
|
-
|
-
|
-
|
Malignant Primary
|
21110080TMA
|
|
59
|
F9
|
64
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110081TMA
|
|
60
|
F10
|
65
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
T2N1M0
|
IIB
|
Malignant Primary
|
21110117TMA
|
|
61
|
G1
|
67
|
F
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110180TMA
|
|
62
|
G2
|
65
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G3
|
-
|
-
|
Malignant Primary
|
21110190TMA
|
|
63
|
G3
|
69
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21115741A
|
|
64
|
G4
|
70
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G3
|
-
|
-
|
Malignant Primary
|
21110341TMA
|
|
65
|
G5
|
71
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110543TMA
|
|
66
|
G6
|
66
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110583TMA
|
|
67
|
G7
|
69
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G3
|
-
|
-
|
Malignant Primary
|
21110046A
|
|
68
|
G8
|
60
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110077A
|
|
69
|
G9
|
69
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110078A
|
|
70
|
G10
|
67
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G3
|
T2N0M0
|
IB
|
Malignant Primary
|
21110084A
|
|
71
|
H1
|
68
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
T2N0M0
|
IB
|
Malignant Primary
|
21110131A
|
|
72
|
H2
|
64
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G3
|
-
|
-
|
Malignant Primary
|
21110148E
|
|
73
|
H3
|
74
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
21110166A
|
|
74
|
H4
|
66
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G3
|
T2bN3M0
|
IIIB
|
Malignant Primary
|
LCS-2304024
|
|
75
|
H5
|
49
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
T2aN3M0
|
IIIB
|
Malignant Primary
|
LCS-2304026
|
|
76
|
H6
|
57
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
T3N2M1a
|
IVA
|
Malignant Primary
|
LCS-2304064
|
|
77
|
H7
|
66
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
T1aN3M0
|
IIIB
|
Malignant Primary
|
LCS-2301037
|
|
78
|
H8
|
69
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
T2aN3M0
|
IIIB
|
Malignant Primary
|
LCS-2301099
|
|
79
|
H9
|
72
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
T2bN3M0
|
IIIB
|
Malignant Primary
|
LCS-2301105
|
|
80
|
H10
|
72
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
T1aN3M0
|
IIIB
|
Malignant Primary
|
LCS-2012220-1B
|
|
81
|
I1
|
68
|
F
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
T1aN3M0
|
IIIB
|
Malignant Primary
|
LCS-2012253-1B
|
|
82
|
I2
|
56
|
M
|
Lung
|
Squamous Cell Carcinoma (Sparse)
|
G2
|
T1aN3M0
|
IIIB
|
Malignant Primary
|
LCS-2304003
|
|
83
|
I3
|
78
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
T2aN3M0
|
IIIB
|
Malignant Primary
|
LCS-2012006-1B
|
|
84
|
I4
|
71
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
T1aN3M0
|
IIIB
|
Malignant Primary
|
LCS-2012059-2
|
|
85
|
I5
|
69
|
F
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
T2bN3M0
|
IIIB
|
Malignant Primary
|
LCS-2012229-2C
|
|
86
|
I6
|
58
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
T1cN3M1a
|
IVA
|
Malignant Primary
|
LCS-2012246-3
|
|
87
|
I7
|
77
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G3
|
T2aN3M0
|
IIIB
|
Malignant Primary
|
LCS-2307068
|
|
88
|
I8
|
52
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G3
|
T2bN3M0
|
IIIB
|
Malignant Primary
|
LCS-2307117
|
|
89
|
I9
|
71
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G3
|
T3N2M1a
|
IVA
|
Malignant Primary
|
LCS-2307119
|
|
90
|
I10
|
67
|
M
|
Lung
|
Squamous Cell Carcinoma
|
G2
|
T2N0M0
|
IB
|
Malignant Primary
|
21110212D
|
|
91
|
J1
|
60
|
M
|
Lung
|
Adenosquamous carcinoma with adenocarcinoma
|
G2
|
-
|
-
|
Malignant Primary
|
17-32380C
|
|
92
|
J2
|
39
|
F
|
Lung
|
Neuroendocrine Carcinoma
|
G3
|
-
|
-
|
Malignant Primary
|
13-8466C
|
|
93
|
J3
|
62
|
M
|
Lung
|
Normal Tissue
|
-
|
-
|
-
|
NAT
|
21115058A
|
|
94
|
J4
|
58
|
M
|
Lung
|
Small Cell Lung Carcinoma
|
IIA
|
-
|
-
|
Malignant Primary
|
F18-05481
|
|
95
|
J5
|
44
|
F
|
Lung
|
Small Cell Lung Carcinoma
|
-
|
-
|
-
|
Malignant Primary
|
2111430A
|
|
96
|
J6
|
62
|
F
|
Lung
|
Small Cell Lung Carcinoma
|
-
|
-
|
-
|
Malignant Primary
|
2111431A
|
|
97
|
J7
|
42
|
F
|
Lung
|
Normal Tissue
|
-
|
-
|
-
|
Normal
|
2014099
|
|
98
|
J8
|
63
|
M
|
Lung
|
Normal Tissue
|
-
|
-
|
-
|
Normal
|
2110735
|
|
99
|
J9
|
48
|
M
|
Lung
|
Normal Tissue
|
-
|
-
|
-
|
NAT
|
2113805
|
|
100
|
J10
|
56
|
M
|
Lung
|
Normal Tissue
|
-
|
-
|
-
|
NAT
|
2110822
|
|
101
|
J11
|
Tissue Marker
|
N-449
|
